Alpha Teknova (TKNO)
(Real Time Quote from BATS)
$2.30 USD
+0.13 (5.99%)
Updated Jul 22, 2024 10:12 AM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Alpha Teknova, Inc. [TKNO]
Reports for Purchase
Showing records 1 - 13 ( 13 total )
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
Life Science Technology: Today''s FDA Approvals Setting CGT Record - Tool Beneficiary Overview
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
3Q23 - Sees Stabilization in Biotechnology Customer Demand
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
Cash Raised, Debt Reduced, Cell Gene Outlook, 2024 Becomes More Interesting
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
2Q23 Beats, Early Stage Programs Weak but GMP Expansion Complete
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
Cryoport Lowers Guidance: Implications for CGT Players
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
Initiating Coverage; Reagent Pure Play; Option on Cell Gene Therapy
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Alpha Teknova, Inc.
Industry: Medical - Biomedical and Genetics
2023 KBCM Life Sciences & MedTech Forum: Day 2 Takeaways
Provider: KeyBanc Capital Markets
Analyst: Research Department
|